Literature DB >> 30265437

Ischemic QRS prolongation as a biomarker of myocardial injury in STEMI patients.

Jakob Almer1, Viktor Elmberg2, Josef Bränsvik1, David Nordlund1, Ardavan Khoshnood3, Michael Ringborn4, Marcus Carlsson1, Ulf Ekelund3, Henrik Engblom1.   

Abstract

BACKGROUND: Patients with acute coronary occlusion (ACO) may not only have ischemia-related ST-segment changes but also changes in the QRS complex. It has recently been shown in dogs that a greater ischemic QRS prolongation (IQP) during ACO is related to lower collateral flow. This suggests that greater IQP could indicate more severe ischemia and thereby more rapid infarct development. Therefore, the purpose was to evaluate the relationship between IQP and measures of myocardial injury in patients presenting with acute ST-elevation myocardial infarction (STEMI).
METHODS: Seventy-seven patients with first-time STEMI were retrospectively included from the recently published SOCCER trial. All patients underwent a cardiac magnetic resonance (CMR) examination 2-6 days after the acute event. Infarct size (IS), myocardium at risk (MaR), and myocardial salvage index (MSI) were assessed and related to IQP. IQP measures assessed were; computer-generated QRS duration, QRS duration at maximum ST deviation, absolute IQP and relative IQP, all derived from a pre-PCI, 12-lead ECG.
RESULTS: Median absolute IQP was 10 ms (range 0-115 ms). There were no statistically significant correlations between measures of IQP and any of the CMR measures of myocardial injury (absolute IQP vs IS, r = 0.03, p = 0.80; MaR, r = -0.01, p = 0.89; MSI, r = -0.05, p = 0.68).
CONCLUSIONS: Unlike previous experimental studies, the IQP was limited in patients presenting at the emergency room with first-time STEMI and no correlation was found between IQP and CMR variables of myocardial injury in these patients. Therefore, IQP does not seem to be a suitable biomarker for triaging patients in this clinical context.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  QRS; acute coronary occlusion; electrocardiography; ischemia

Mesh:

Substances:

Year:  2018        PMID: 30265437      PMCID: PMC6931768          DOI: 10.1111/anec.12601

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  26 in total

1.  QRS changes during percutaneous transluminal coronary angioplasty and their possible mechanisms.

Authors:  B Surawicz; C M Orr; J B Hermiller; K D Bell; R P Pinto
Journal:  J Am Coll Cardiol       Date:  1997-08       Impact factor: 24.094

2.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.

Authors:  Alan D Lopez; Colin D Mathers; Majid Ezzati; Dean T Jamison; Christopher J L Murray
Journal:  Lancet       Date:  2006-05-27       Impact factor: 79.321

3.  Ischemic QRS prolongation as a biomarker of myocardial injury in STEMI patients.

Authors:  Jakob Almer; Viktor Elmberg; Josef Bränsvik; David Nordlund; Ardavan Khoshnood; Michael Ringborn; Marcus Carlsson; Ulf Ekelund; Henrik Engblom
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-09-28       Impact factor: 1.468

4.  QRS complex and ST segment manifestations of ventricular ischemia: the effect of regional slowing of ventricular activation.

Authors:  Ljuba Bacharova; Vavrinec Szathmary; Anton Mateasik
Journal:  J Electrocardiol       Date:  2013-09-24       Impact factor: 1.438

5.  A modified Anderson-Wilkins electrocardiographic acuteness score for anterior or inferior myocardial infarction.

Authors:  Bo Hedén; Rasmus Ripa; Eva Persson; Qianzi Song; Charles Maynard; Paul Leibrandt; Thomas Wall; Timothy F Christian; Stephen C Hammill; Samuel S Bell; Olle Pahlm; Galen S Wagner
Journal:  Am Heart J       Date:  2003-11       Impact factor: 4.749

6.  Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography.

Authors:  Peder Sörensson; Einar Heiberg; Nawsad Saleh; Frederic Bouvier; Kenneth Caidahl; Per Tornvall; Lars Rydén; John Pernow; Håkan Arheden
Journal:  J Cardiovasc Magn Reson       Date:  2010-04-30       Impact factor: 5.364

Review 7.  Acute myocardial infarction.

Authors:  Grant W Reed; Jeffrey E Rossi; Christopher P Cannon
Journal:  Lancet       Date:  2016-08-05       Impact factor: 79.321

Review 8.  Acute coronary syndromes: diagnosis and management, part I.

Authors:  Amit Kumar; Christopher P Cannon
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616

9.  The relationship between terminal QRS distortion on initial ECG and final infarct size at 4months in conventional ST- segment elevation myocardial infarct patients.

Authors:  M E C J Hassell; R Delewi; C P H Lexis; M W Smulders; A Hirsch; G Wagner; S C A M Bekkers; I C C van der Horst; F Zijlstra; A C van Rossum; J J Piek; P van der Harst; R Nijveldt
Journal:  J Electrocardiol       Date:  2016-03-05       Impact factor: 1.438

10.  Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study.

Authors:  Einar Heiberg; Martin Ugander; Henrik Engblom; Matthias Götberg; Göran K Olivecrona; David Erlinge; Håkan Arheden
Journal:  Radiology       Date:  2007-11-30       Impact factor: 11.105

View more
  1 in total

1.  Ischemic QRS prolongation as a biomarker of myocardial injury in STEMI patients.

Authors:  Jakob Almer; Viktor Elmberg; Josef Bränsvik; David Nordlund; Ardavan Khoshnood; Michael Ringborn; Marcus Carlsson; Ulf Ekelund; Henrik Engblom
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-09-28       Impact factor: 1.468

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.